Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2016

Pharma News, 2016

From flour to starch, fake antibiotic drugs have them all
From flour to starch, fake antibiotic drugs have them all
AHMEDABAD.
ViiV Healthcare announces start of phase III study evaluating long-acting cabotegravir for HIV prevention
ViiV Healthcare announces start of phase III study evaluating long-acting cabotegravir for HIV prevention
ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc.
FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions
FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions
The U.
FDA grants accelerated approval to new treatment for advanced ovarian cancer
FDA grants accelerated approval to new treatment for advanced ovarian cancer
The U.
20 States Accuse Generic Drug Companies of Price Fixing
20 States Accuse Generic Drug Companies of Price Fixing
A wide-ranging investigation into generic drug prices took its most significant turn yet on Thursday, as state attorneys general accused two industry leaders, Teva Pharmaceuticals and Mylan, and four ...
FDA Removes Black Box Warning from Varenicline's Label
FDA Removes Black Box Warning from Varenicline's Label
The FDA has agreed to remove the black box warning from the label of the smoking-cessation drug, varenicline (Chantix).
Merck wins $2.54 billion in hepatitis C drug trial against Gilead
Merck wins $2.54 billion in hepatitis C drug trial against Gilead
Merck & Co on Thursday was awarded $2.
HIV drugs may take a toll on brain: study
HIV drugs may take a toll on brain: study
Washington.
Xtandi, cornerstone of Pfizer's $14B Medivation buy, falls short in closely watched study
Xtandi, cornerstone of Pfizer's $14B Medivation buy, falls short in closely watched study
Pfizer rolled out the first round of new data since it closed on Xtandi-maker Medivation in September—and the results weren’t good.
R&D productivity recovery? Deloitte sees no sign just yet
R&D productivity recovery? Deloitte sees no sign just yet
Return on R&D among the world's largest pharma companies are still in free fall with no signs of a recovery, says Deloitte.
Pfizer gets letter from US senators seek information on drug to treat opioid overdoses
Pfizer gets letter from US senators seek information on drug to treat opioid overdoses
Senator Claire McCaskill, a Democrat from Missouri, makes an opening statement during a Senate Consumer Protection, Product Safety, and Insurance subcommittee hearing with Mary Barra, chief executive ...
CoLucid Pharmaceuticals Inc. (CLCD) Coverage Initiated by Analysts at Barclays PLC
CoLucid Pharmaceuticals Inc. (CLCD) Coverage Initiated by Analysts at Barclays PLC
Barclays PLC began coverage on shares of CoLucid Pharmaceuticals Inc.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand